▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Todd Campbell

tmfebcapital

@ebcapital

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Recent Articles by Todd Campbell

Jun 29, 2014 by Todd Campbell

Defense Department Deal Ignites Bidding War

Allscripts (MDRX), Computer Sciences (CSC), and Hewlett Packard (HPQ) are teaming up in a bid to win an $11 billion contract with the Department of Defense to create a new electronic health records system.

Jun 29, 2014 by Todd Campbell

Is a Rite Aid RediClinic Coming to a Store Near You?

Rite Aid acquired RediClinic in February to launch into in-store health clinics. The company plans to open up to 70 clinics this year in a bid to better compete against CVS and Walgreen.

Jun 29, 2014 by Todd Campbell

Is Obamacare Really Saving People Money?

A Kaiser Family Foundation study shows an even split between those saving or paying more for healthcare insurance, calling into question whether people signing up for UnitedHealth Group (UNH) or WellPoint (WLP) plans will keep paying.

Jun 29, 2014 by Todd Campbell

Are Obamacare Co-Ops Disrupting Insurers?

Health-care co-ops signed up hundreds of thousands of new members during Obamacare's first open enrollment, but that may not be cause for worry by Aetna and WellPoint investors.

Jun 28, 2014 by Todd Campbell

Why Some Insurers Will Cheer This Obamacare Failure

Arkansas private option Medicaid program is over budget, which could eventually mean more members for UnitedHealth's (UNH), WellPoint's (WLP) and Molina's (MOH) Medicaid business.

Jun 28, 2014 by Todd Campbell

Obamacare Subsidies: Effective or $12 Billion Boondoggle?

Obamacare subsidies save members thousands each year on plans offered by WellPoint and Aetna.

Jun 27, 2014 by Todd Campbell

Is GlaxoSmithKline's Dividend Safe?

Here's what you need to know about patent expiration's potential impact on GlaxoSmithKline's (GSK) dividend payout.

Jun 26, 2014 by Todd Campbell

18 Quotes from Rite Aid That Every Investor Should Read

Here are 18 quotes from Rite Aid (RAD) management concerning Rite Aid's current and future business plans that every investor should read.

Jun 26, 2014 by Todd Campbell

Is Novartis' Dividend Safe?

Here's what you need to know about Novartis' (NVS) dividend payout.

Jun 26, 2014 by Todd Campbell

Is Rite Aid a Better Buy than Walgreen?

This presentation breaks out the key considerations investors should know about if they're thinking about buying shares in Walgreen (WAG) or Rite Aid (RAD).

Jun 24, 2014 by Todd Campbell

Here's What's Driving Results at Walgreen

Walgreen may have missed on earnings this quarter, but over the long term it continues to look intriguing.

Jun 24, 2014 by Todd Campbell

Up 40%: Is Vertex's Surge Justified?

Vertex (VRTX) shares jumped 40% on news that its treatment for cystic fibrosis met endpoints in late-stage trials.

Jun 23, 2014 by Todd Campbell

Is Sanofi's Dividend Safe?

The threat of patent expiration on Lantus and competing diabetes drugs from Eli Lilly (LLY) and Novo Nordisk (NVO) could weigh on Sanofi's (SNY) dividend.

Jun 23, 2014 by Todd Campbell

Is Shire's Dividend Safe?

Shire is losing patent protection on a key ADHD drug this year, but should dividend investors be concerned?

Jun 22, 2014 by Todd Campbell

Here's Why AbbVie Wants to Cozy Up With Shire

AbbVie (ABBV) has reportedly made three offers to acquire Shire (SHPG) in a bid to lock up Shire's ADHD and rare drug franchise and capitalize on Shire's tax-friendly Irish address.

Jun 22, 2014 by Todd Campbell

Time to Invest in America's Fastest-Growing Industry?

Aging baby boomers are likely to drive demand for home health providers Gentiva (GTIV), Healthsouth (HRC), and Amedisys (AMED) in the coming decade.

Jun 21, 2014 by Todd Campbell

Could This Surprising Trend Blow Away Obamacare?

Private healthcare exchanges offered by companies including Aon Hewitt and Towers Watson could end up having a bigger long term impact on insurers like United Healthcare than Obamacare.

Jun 20, 2014 by Todd Campbell

Are Generic Drugs Hurting Rite Aid?

Rite Aid's (RAD) generic drug outsourcing deal with McKesson (MCK) underwhelmed last quarter.

Jun 19, 2014 by Todd Campbell

Is Aetna's Dividend Safe?

Here's what you need to know about Obamacare's impact on Aetna's (AET) dividend and how Aetna's dividend matches up against peers UnitedHealth (UNH) and WellPoint (WLP).

Jun 19, 2014 by Todd Campbell

3 Key Opportunities for Medtronic and Covidien

Medtronic is buying Covidien in a tax-friendly move, but here are three other reasons the deal makes sense.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services